← Retour au Screener

Sector: Santé
Open in Terminal → VEEVLive chart · Key metrics · News · Smart money

Veeva Systems Inc.

VEEV Large Cap

Healthcare · Health Information Services

Mis à jour: Jun 18, 2026, 22:21 UTC

133,84 €
-0.96% aujourd'hui
52W: 129,20 € – 270,97 €
52W Low: 129,20 € Position: 3.3% 52W High: 270,97 €

Price Chart

Indicateurs clés

P/E Ratio
27.19x
Cours/Bénéfice
Forward P/E
15.28x
P/E prévisionnel
P/S Ratio
7.51x
Cours/Ventes
EV/EBITDA
18.84x
Valeur d'entreprise/EBITDA
Rend. dividende
Rendement annuel du dividende
Cap. boursière
21,7 Md €
Capitalisation boursière
Croissance du CA
16.3%
Croissance du CA sur un an
Marge bénéficiaire
28.37%
Marge nette
ROE
13.93%
Rentabilité des capitaux propres
Beta
0.95
Sensibilité au marché
Positions vendeuses
5.9%
% du flottant vendu à découvert
Volume moyen
3,027,239
Volume quotidien moyen

Valuation Analysis

Signal
Fair
vs. S&P 500 avg P/E (24.7x)
Analyst Consensus
Acheter
27 analysts
Avg. Price Target
214,22 €
+60.06% upside
Target Range
143,99 € – 305,44 €

About the Company

Sector: Healthcare Industry: Health Information Services Country: United States Employees: 7,928 Exchange: NYQ

Veeva Systems Inc. en bref

Veeva Systems Inc. (VEEV) is currently trading at 133,84 € with a market capitalization of 21,7 Md €. The trailing P/E ratio stands at 27.19x, with a forward P/E of 15.28x. The 52-week range spans from 129,20 € to 270,97 €; the current price is 50.6% below the yearly high. Year-over-year revenue growth stands at +16.3%. The net profit margin stands at 28.37%.

💰 Dividende

Veeva Systems Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

27 analystes évaluent Veeva Systems Inc. (VEEV) au consensus : Acheter. L'objectif de cours moyen est de 214,22 €, soit un potentiel de +60.06% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 143,99 € à 305,44 €.

Veeva Systems Inc. : la thèse d'investissement en détail

Veeva Systems Inc. (VEEV) operates in the Healthcare — specifically Health Information Services — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Revenue is growing at a healthy 16.3% pace year-over-year, suggesting the business model continues to find new customers and pricing power. With a gross margin near 75.02%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Free cash flow is positive and net margins stand at 28.37%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

Valorisation en contexte

With a PEG ratio of 0.74, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

  • The forward P/E of 15.28x is meaningfully below the trailing 27.19x — analysts expect earnings to step up; the next earnings release is the test.
  • The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
  • The analyst consensus price target implies 60.06% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Points forts
  • Rentable avec une marge nette de 28.37%
  • Marge brute élevée de 75.02% — signe d'un pouvoir de fixation des prix
  • Consensus des analystes : Buy
  • Bilan solide avec faible endettement (D/E 1.41)
  • Free cash flow positif
Points faibles

Aucun signal d'alerte significatif dans les indicateurs actuels.

Aperçu technique

MM 50 jours
143,45 €
-6.7% vs. cours
MM 200 jours
190,86 €
-29.88% vs. cours
Sous le plus haut 52s
−50.6%
270,97 €
Au-dessus du plus bas 52s
+3.6%
129,20 €

Price is below both the 50- and 200-day moving averages, with 50d below 200d — a bearish picture (death-cross alignment).

Profil de risque

Risque de marché (Bêta)
0.95 · Proche du marché
Évolue moins que le marché global
Positions vendeuses
5.9% · Élevé
% du flottant vendu à découvert
Dette/Capitaux propres
1.41 · Faible
Dette totale / capitaux propres

The data points to relatively defensive market behavior, elevated short interest (5.9%).

Trading Data

50-Day MA: 143,45 €
200-Day MA: 190,86 €
Volume: 2,050,166
Avg. Volume: 3,027,239
Short Ratio: 2.04
P/B Ratio: 3.48x
Debt/Equity: 1.41x
Free Cash Flow: 1,1 Md €

More Santé stocks

Top peers in the same sector — ranked by market cap.

View full Santé sector page →

Where can I buy Veeva Systems Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.

Live Market Data

Real-time chart, financials, earnings, analysts, insider trades, events & news

Financials

Earnings

Analyst Ratings

Insider Trades

Events Timeline

News + Sentiment

Peer Comparison

Retour en haut